1 |
费贵军,侍效春,杨爱明.真菌性食管炎临床分析[J].基础医学与临床,2017(10):1449-1451.
|
2 |
Corning B, Copland AP, Frye JW.The Esophageal Microbiome in Health and Disease[J]. Curr Gastroenterol Rep, 2018, 20(8): 39.
|
3 |
Kodsi BE, Wickremesinghe C, Kozinn PJ, et al.Candida esophagitis: a prospective study of 27 cases[J]. Gastroenterology, 1976, 71(5): 715-719.
|
4 |
May M, Abrams JA.Emerging Insights into the Esophageal Microbiome[J]. Curr Treat Options Gastroenterol, 2018, 16(1): 72-85.
|
5 |
Mulhall BP, Wong RK.Infectious Esophagitis[J]. Curr Treat Options Gastroenterol, 2003, 6(1): 55-70.
|
6 |
Prasad R. Candida albicans, cellular and molecular biology[M]. Berlin: Springer-Verlag, 1991.
|
7 |
Wilcox CM.Overview of infectious esophagitis[J]. Gastroenterol Hepatol(N Y), 2013, 9(8): 517-519.
|
8 |
Smith LA, Gangopadhyay M, Gaya DR.Catastrophic gastrointestinal complication of systemic immunosuppression[J]. World J Gastroenterol, 2015, 21(8): 2542-2545.
|
9 |
Kanda N, Yasuba H, Takahashi T, et al.Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate[J]. Am J Gastroenterol, 2003, 98(10): 2146-2148.
|
10 |
SHEN S, JI H, GUO X, et al.Application of Computed Tomography to Diagnose Fungal Esophagitis: One Case Report[J]. AIDS Res Hum Retroviruses, 2019, 35(5): 425-427.
|
11 |
廖治宇.真菌性食管炎的临床诊断与治疗[J].世界最新医学信息文摘,2016(61):320-324.
|
12 |
Pappas PG, Kauffman CA, Andes DR, et al.Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016, 62(4): 409-417.
|
13 |
Hojo M, Asahara T, NagaharaA, et al.Gut microbiota composition before and after use of proton pump inhibitors[J]. Dig Dis Sci, 2018, 63(11): 2940-2949.
|
14 |
Wilson A, Delport J, Ponich T. Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?[J]. Int J Microbiol, 2014, 2014: 371631.
|
15 |
Kondo T, Terada K. Candida Esophagitis[J]. N Engl J Med, 2017, 376(16): 1574.
|
16 |
Mushi MF, Ngeta N, Mirambo MM, et al.Predictors of esophageal candidiasis among patients attending endoscopy unit in a tertiary hospital, Tanzania: a retrospective cross-sectional study[J]. African Health Sciences, 2018, 18(1): 66.
|
17 |
Daniell HW.Acid suppressing therapy as a risk factor for Candida esophagitis[J]. Dis Esophagus, 2016, 29(5): 479-483.
|
18 |
O′Rourke A. Infective oesophagitis: epidemiology, cause, diagnosis and treatment options[J]. Curr Opin Otolaryngol Head Neck Surg, 2015, 23(6): 459-463.
|